Retraction notice to “Beneficial Effect of Etidronate Therapy in Chronically Hospitalized, Disabled Patients with Stroke” (Journal of Stroke and Cerebrovascular Diseases (2010) 19(3) (198–203), (S1052305709000925), (10.1016/j.jstrokecerebrovasdis.2009.04.006));Beneficial Effect of Etidronate Therapy in Chronically Hospitalized, Disabled Patients with Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 19, Issue 3, 2010, Pages 198-203

  Sato, Yoshihiro ^a   Iwamoto, Jun ^b   Honda, Yoshiaki ^a  

^a Mitate Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Etidronate; hemiplegia; hip fracture; immobilization; osteoporosis

Indexed keywords

CALCIUM ION; DEOXYPYRIDINOLINE; ETIDRONIC ACID; PLACEBO;

ABDOMINAL PAIN; AGED; ANOREXIA; ARTICLE; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABLED PERSON; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; FEMALE; HEMIPARESIS; HIP FRACTURE; HUMAN; IMMOBILIZATION; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINE LEVEL;

EID: 77953162123     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2019.03.034     Document Type: Erratum

References (25)

1. Ramnemark A., Nyberg L., Borssén B., et al. Fractures after stroke. Osteoporos Int 8 (1998) 92-95
2. Sato Y., Maruoka H., Honda Y., et al. Development osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol 36 (1996) 278-283
3. Sato Y., Kuno H., Kaji M., et al. Increased bone resorption during the first year following a stroke. Stroke 29 (1998) 1373-1377
4. Sato Y., Maruoka H., Oizumi K., et al. Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke 27 (1996) 2183-2187
5. Sato Y., Kuno H., Kaji M., et al. Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke. J Neurol Sci 175 (2000) 135-139
6. Sato Y., Iwamoto J., Kanoko T., et al. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 64 (2005) 811-816
7. Fleish H. Bisphosphonate: History and mechanism of action. Metab Bone Dis Relate Res 3 (1981) 279-287
8. Storm T., Thamsborg G., Steiniche T., et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322 (1990) 1265-1271
9. Harris S.T., Watts N.B., Jackson R.D., et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy. Am J Med 95 (1993) 557-567
10. Sato Y., Asoh T., Kaji M., et al. Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke. J Bone Miner Res 15 (2000) 2487-2494
11. Sato Y., Honda Y., Asoh T., Kikuyama M., et al. Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol 37 (1997) 225-229
12. Mahoney F.I., and Barthel D.W. Functional evaluation: The Barthel index. Md St Med J 14 (1965) 61-65
13. Komar L., Nieves J., Cosman F., et al. Calcium homeostasis of an elderly population upon admission to a nursing home. J Am Geriatr Soc 41 (1993) 1057-1064
14. Matsumoto C., Kushida K., Yamazaki K., et al. Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif Tissue Int 55 (1994) 324-329
15. Sato Y., Iwamoto J., Kanoko T., et al. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 165 (2005) 1743-1748
16. Sato Y., Manabe S., Kuno H., et al. Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in Parkinson's disease. J Neurol Neurosurg Psychiatry 66 (1999) 64-68
17. Ishihara C., Kushida K., and Takahashi M. The efficacy of biochemical markers in patients with ossification of posterior longitudinal ligament of the spine. Spinal Cord 38 (2000) 211-213
18. Sato Y., Kuno H., Asoh T., et al. Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients. Age Ageing 28 (1999) 265-269
19. Hagino H., Yamamoto K., Ohshiro H., et al. Changing incidence of hip, distal radius, and proximal humerus fractures in Tottori Prefecture, Japan. Bone 24 (1999) 265-270
20. Cortet B., Béra-Louville A., Gauthier P., et al. Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis: Effect of adding hormone replacement therapy. Joint Bone Spine 68 (2001) 410-415
21. Lyritis G.P., Tsakalakos N., Paspati I., et al. The effect of a modified etidronate cyclical regimen on postmenopausal osteoporosis: A four-year study. Clin Rheumatol 16 (1997) 354-360
22. Tobias J.H., Dalzell N., Pazianas M., et al. Cyclical etidronate prevents spinal bone loss in early post-menopausal women. Br J Rheumatol 36 (1997) 612-613
23. Chapuy M.C., Arlot M.E., Duboeuf F., et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327 (1992) 1637-1642
24. Sato Y., Fujimatsu Y., Kikuyama M., et al. Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. J Neurol Sci 156 (1998) 205-210
25. Sato Y., Oizumi K., Kuno H., et al. Effect of Immobilization upon renal synthesis of 1, 25-dihydroxyvitamin D in disabled elderly stroke patients. Bone 24 (1999) 271-275